Merck (MRK) Shares Repurchased (2010 - 2026)

Merck (MRK) reported Shares Repurchased of $874.0 million for Q1 2026, down 24.91% year-over-year from $1.2 billion in Q1 2025, and down 30.19% quarter-over-quarter from $1.3 billion in Q4 2025.

Merck (MRK) Shares Repurchased (2010 - 2026) Analysis & Trends

Merck (MRK) has 16 years of Shares Repurchased data on file, last reported at $874.0 million in Q1 2026.

  • Shares Repurchased for Q1 2026 came in at $874.0 million, down 24.91% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.8 billion (up 104.17% YoY), and the FY2025 annual result was $5.1 billion, up 289.28% from the prior year.
  • Shares Repurchased fell to $874.0 million in Q1 2026 per MRK's latest filing, from $1.3 billion in the prior quarter.
  • Over five years, Shares Repurchased peaked at $1.3 billion in Q2 2025 and troughed at $122.0 million in Q1 2024.
  • A 4-year average of $662.3 million and a median of $466.0 million in 2023 frame the typical range for Shares Repurchased.
  • The sharpest annual moves came in 2024 and 2025: Shares Repurchased dropped 25.74% in 2024, then surged 854.1% in 2025.
  • A 4-year view of Shares Repurchased shows it stood at $393.0 million in 2023, then grew by 24.43% to $489.0 million in 2024, then surged by 156.03% to $1.3 billion in 2025, then sank by 30.19% to $874.0 million in 2026.
  • Business Quant data shows MRK's Shares Repurchased at $874.0 million in Q1 2026, $1.3 billion in Q4 2025, and $1.3 billion in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Repurchased (Qtr)
1 Gsk 93,699,046.73 Bn 93,699,041.77 Bn 7.76 Bn -439.51 Mn
2 Eli Lilly 1,012.06 Bn 1,006.77 Bn 16.22 Bn 2.36 Bn
3 Johnson & Johnson 560.67 Bn 538.62 Bn 15.96 Bn 4.03 Bn
4 AbbVie 402.20 Bn 392.85 Bn 10.78 Bn 1.49 Bn
5 Merck 298.59 Bn 292.94 Bn 12.09 Bn 874.00 Mn
6 Amgen 188.77 Bn 176.74 Bn 5.87 Bn -
7 Gilead Sciences 160.22 Bn 152.49 Bn 5.52 Bn 419.00 Mn
8 Pfizer 148.19 Bn 135.42 Bn -1.21 Bn -
9 Bristol Myers Squibb 116.72 Bn 106.26 Bn 8.07 Bn -
10 Novartis Ag 109.78 Bn 109.09 Bn - -

Historic Data

Download Data
DateValue
Mar 31, 2026 874.00 Mn
Mar 31, 2026 874.00 Mn
Dec 31, 2025 1.25 Bn
Dec 31, 2025 1.25 Bn
Sep 30, 2025 1.32 Bn
Sep 30, 2025 1.32 Bn
Jun 30, 2025 1.35 Bn
Jun 30, 2025 1.35 Bn
Mar 31, 2025 1.16 Bn
Mar 31, 2025 1.16 Bn
Dec 31, 2024 489.00 Mn
Dec 31, 2024 489.00 Mn
Sep 30, 2024 444.00 Mn
Sep 30, 2024 444.00 Mn
Jun 30, 2024 251.00 Mn
Jun 30, 2024 251.00 Mn
Mar 31, 2024 122.00 Mn
Mar 31, 2024 122.00 Mn
Dec 31, 2023 393.00 Mn
Dec 31, 2023 393.00 Mn